Speaker illustration

Professor Helen Colhoun

Edinburgh (United Kingdom of Great Britain & Northern Ireland)

Novel anti-obesity drugs in weight management.

Event: ESC Congress 2022

Topic: Obesity and Diabetes

Session: Obesity and CV disease – Lowering CV risk with novel weight loss strategies


Cardiovascular outcomes in patients with type 2 diabetes and reduced eGFR and albuminuria: a REWIND post hoc subgroup analysis

Event: ESC Congress 2020

Topic: Antidiabetic Pharmacotherapy

Session: Improving Cardiovascular Function and Clinical Outcome in Diabetes Using New Guideline-Based Pharmacotherapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb